Characteristic | Â |
---|---|
Age, years | Â |
• Mean (SD) | 40.69 (15.52) |
• Range | 12.0-78.0 |
• Median | 41.0 |
• IQR | 27.0, 52.0 |
Gender, n (%) | Â |
• Female | 132 (54.32) |
Ethnicity | Â |
• Caucasian | 177 (72.84) |
Body mass index, mg/kg2 | Â |
• Mean (SD) | 28.15 (6.85) |
• Range | 15.21-54.71 |
• Median | 26.58 |
• IQR | 23.34, 31.19 |
Body mass index, mg/kg2, n (%) | Â |
• Underweight (<18.5) | 4 (1.72) |
• Normal (18.5-24.9) | 86 (36.91) |
• Overweight (25–29.9) | 73 (31.33) |
• Obese (>30.0) | 70 (30.04) |
Smoking status, physican-reported, n (%) | Â |
• Current smoker | 8 (3.29) |
• Ex-smoker | 43 (17.70) |
• Never smoked | 192 (79.01) |
Physician-reported pack years, n (%) | Â |
• High (≥10) | 29 (11.93) |
• Low (<10) | 22 (9.05) |
• Never smoked | 192 (79.01) |
Lung function (FEV1) | Â |
• Mean (SD) | 73.65 (17.80) |
• Range | 25.0-138.0 |
• Median | 70.0 |
• IQR | 63.5, 82.0 |
Frequency of asthma exacerbations in last 12 months | Â |
• Mean (SD) | 1.08 (1.90) |
• Range | 0.0-14.0 |
• Median | 0.0 |
• Range | 0.0, 2.0 |
Frequency of asthma exacerbations in last 12 months, n (%) | Â |
• 0 | 134 (55.14) |
• 1 | 44 (18.11) |
• ≥2 | 65 (26.75) |
Deyo Charlson Comorbidity Indexa [58] | Â |
• Mean (SD) | 0.13 (0.53) |
• Range | 0-6 |
• Median | 0 |
• IQR | 0, 0 |
Most common concomitant conditions, n (%) | Â |
• Allergic rhinitis | 115 (47.33) |
• Gastroesophageal reflux disease | 42 (18.26) |
• Anxiety | 36 (15.65) |
• Obesity | 27 (11.74) |
• Cardiovascular diseasec | 15 (6.17) |
• None | 45 (18.52) |
Physician managing patient’s asthma, n (%) |  |
• Primary care- only | 69 (28.40) |
• Specialist-led | 174 (71.60) |
Morisky Medication Adherence Scale, n (%) | Â |
• Low | 97 (39.92) |
• Medium | 89 (36.63) |
• High | 57 (23.46) |
Asthma Control Test | Â |
• Mean (SD) | 19.91 (3.94) |
• Range | 6-25 |
• Median | 20 |
• IQR | 18, 23 |
Asthma Control Test, n (%) | Â |
• 5-19 (Not well controlled) | 99 (40.74) |
• ≥20 (Well controlled) | 144 (59.26) |
Jenkins Sleep Evaluation Questionnaireb | Â |
• Mean (SD) | 4.02 (4.53) |
• Range | 0-20 |
• Median | 3 |
• IQR | 0, 6 |
Jenkins Sleep Evaluation Questionnaireb, n (%) | Â |
• 0 | 76 (31.28) |
• 1-5 | 97 (39.92) |
• 6-10 | 44 (18.11) |
• 11-15 | 21 (8.64) |
• 16-20 | 5 (2.06) |
EuroQol-5D-3L | Â |
• Mean (SD) | 0.91 (0.14) |
• Range | 0.27-1 |
• Median | 1 |
• IQR | 0.84, 1 |